Antidepressants in primary care

WEBINAR archive 2017: Associate Professor David Menkes and Professor Bruce Arroll discussed the evidence for the benefit for antidepressants in primary care, as well as cases to support key points.

Clozapine. Malignant constipation can kill

Clozapine is used for treatment-resistant schizophrenia. Agranulocytosis and neutropenia are the usual concerns but there are more deaths from ileus/megacolon.

Webinar: Statins; who, when, where and why

In this webinar Dr Tony Scott, cardiologist talked about the use of statins in primary care and dealt with questions such as 'are all statins equal?' and 'how do you prescribe statins and maintain medication compliance?" 

Also covered was how to approach discussions around the size of the benefit to enable patients to be fully informed (re taking statins) and how to discuss potential harms eg., dementia, diabetes, fatigue and muscle aches.


Beta-blockers no longer first line for simple hypertension

Initiating treatment of hypertension with beta-blockers leads to modest CVD reductions and little or no effects on mortality (atenolol mainly studied).

Maintenance GAHT prescribing for adult transgender patients

MedCase: Repeat prescribing for patients already commenced gender-affirming hormone therapy.

Liraglutide for weight management

Liraglutide (brand name: Saxenda®) is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that is indicated, alongside lifestyle measures, for weight management in adults who have obesity or overweight with at least one weight-related comorbidity.

This MedCase describes how to start liraglutide and support patients with weight loss in a general practice setting.

Dulaglutide for type 2 diabetes management

The place of dulaglutide (brand name Trulicity) alongside other therapies.

Optimising therapy for type 2 diabetes with empagliflozin (Jardiance)

MedCase: the place of empagliflozin alongside existing treatments and describes how to safely start treatment.


Subscribe to Medication